The International Lung Screen Trial (ILST) aims to establish the optimal selection criteria for low-dose computed tomography screening of individuals at high risk for developing lung cancer, and to evaluate the PanCan model for managing screen-detected nodules.
Results
Stephen Lam discusses the interim findings from the ILST indicating that changing eligibility criteria can improve identification of high-risk individuals (5:36):